D
LIVE

Serial Number

97821995

Owner

Dewpoint Therapeutics, Inc.

Attorney

Christina M. Licursi

Filing Date

Mar 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

D Trademark

Serial Number: 97821995

D is a trademark filed by Dewpoint Therapeutics, Inc. on March 3, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Dewpoint Therapeutics, Inc. (15 trademarks)

Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

March 3, 2023

Registration Date

Not Registered

Published for Opposition

April 9, 2024

Goods & Services

Downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the fields of scientific research and drug discovery

Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; Reagents for medical use; Reagents for clinical use in the nature of clinical medical use

Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use in the nature of diagnostic reagents for clinical and medical laboratory use

Scientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; Scientific, biological, pharmaceutical and medical research services; Laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; Pharmaceutical drug discovery and drug development services; Biological research and development services; Scientific condensate-based research in the field of drug discovery and drug development; Providing temporary use of online, non-downloadable computer software using artificial intelligence for machine learning, integrated databases and workflow processes for use in the fields of scientific research and drug discovery

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 4, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 4, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 3, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 3, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 3, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 2, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 2, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 27, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 24, 2023 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2023 NWOS